<DOC>
	<DOCNO>NCT00249821</DOCNO>
	<brief_summary>Multicentric , open-label , randomize , pilot comparative study parallel group compare 1 group subject receive 0.057 milligram/kilogram/day ( mg/kg/day ) 0.40 mg/kg/week Saizen® 1 year 1 group receive 0.035 mg/kg/day ( 0.24 mg/kg/week ) Saizen® 1 year initial 3-year treatment recombinant human growth hormone ( r-hGH ) therapy 0.057 mg/kg/day group .</brief_summary>
	<brief_title>Optimization Dosage Regimen Growth Hormone Therapy Children Born Small Gestational Age</brief_title>
	<detailed_description />
	<mesh_term>Hormones</mesh_term>
	<criteria>To eligible inclusion / randomization study , subject must fulfill follow criterion ( inclusion phase , inclusion criterion consider inclusion criterion randomization ) : Written consent form sign parent / legal guardian , child possible Subject bear SGA receive rhGH therapy pathology Recombinant human growth hormone ( rhGH ) start maximal chronological age 7 year girls 8 year boys Treatment rhGH start least 30 month le 36 month 0.057 mg/kg/day Height gain first 2 year GH treatment &gt; 1 SD compare initial value To eligible inclusion study subject must meet following criterion : Known hypersensitivity Somatropin excipients Active neoplasia ( either newly diagnose recurrent ) Intracranial hypertension Known diabetes mellitus Proliferative preproliferative diabetic retinopathy Evidence progression recurrence underlie intracranial space occupy lesion Obesity define degree 1 corpulence curve Precocious puberty Pubertal status : Tanner breast development stage &gt; 2 girl , testicular volume &gt; 4 milliliter ( mL ) testicular length &gt; 3 centimeter ( cm ) and/or testosterone value &gt; 1 nanomole/liter [ nmol/L ] ( 0.29 gram/mL [ g/mL ] ) boys For girl &gt; 9 year Tanner breast development stage 1 : uterine size &gt; 35 millimeter ( mm ) Severe chronic concomitant illness chronic renal failure , cystic fibrosis Concomitant corticoid treatment levothyroxine treatment substitutive treatment , topical inhale treatment Participation clinical study within 30 day precede study entry</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>